Special Issue "Novel Anti-Proliferative Agents 2024"
Deadline for manuscript submissions: 25 June 2024 | Viewed by 577
Interests: medicinal chemistry; nitrogen heterocycles; antiproliferative compounds; enzyme inhibitors
Special Issues, Collections and Topics in MDPI journals
Cancer is one of the most widely spread and complex forms of disease, as cancer cells are distinguished from healthy cells due to their altered proliferation and survival. In the past three decades, the National Cancer Institute (NCI) alone has screened millions of small molecules for potential anticancer activity. Despite a number of conventional cytotoxic approaches having been developed, their limited effectiveness, in accordance with the heterogeneity of cancer cells, prompts the constant search for novel natural or synthetic compounds with properties involved in growth inhibition or tumor cell activity reduction.
This Special Issue of Pharmaceuticals invites both reviews and original articles regarding basic, preclinical and clinical studies on antiproliferative chemical entities.
I look forward to receiving your contributions.
Prof. Dr. Valentina Onnis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- medicinal chemistry
- drug discovery
- natural compounds
- synthetic compounds
- organic synthesis
- anticancer drugs
- antiproliferative activity